An observational study in Stroke, Brain Ischemia and Adipokines, sponsored by Xi'an No.3 Hospital. Recruiting at 1 site in China. Per ClinicalTrials.gov, last updated 2017-04-24.
Sponsored by Xi'an No.3 Hospital · Observational
This observational study aims to research whether there is a relationship between omentin and ischemic stroke on the aspects of incidence, severity, and recovery etc.
To study the possible relationship between omentin and ischemic stroke, we intend to recruit the newly found acute ischemic stroke patients and patients without any stroke history and analysis the difference of plasma omentin level and the ITLN, which is the gene symbol of omentin.
2,612 studies on the registry are indexed under Ischemic Stroke; 971 are open to participants now.
This study's planned enrollment of 2,000 is above the median of 300 across 771 observational studies indexed under Ischemic Stroke.
Browse Ischemic Stroke studies →Xi'an No.3 Hospital is the lead sponsor of 7 studies on the registry; 7 are open to participants now.
Compared within Ischemic Stroke, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Stroke. The counts are of registry records indexed under each term, refreshed daily. How we classify →
the study population is from primary care clinic, physical examination center, and social volunteers.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
For ischemic stroke group
patients without any history of stroke
patients with an episode of neurological dysfunction caused by focal cerebral, spinal, or retinal infarction within 72 hours.
the odds ratio of omentin plasma concentration between cases and controls
The circulation level of omentin will be assessed in cases and controls. Then the odds ratio will be statically analysed to detect whether omentin is asociated with ischemic stroke on protein level.
Time frame: up to 3 years
the frequency difference of single nucleotide polymorphism(SNP) of omentin in the enrolled subjects
The SNP will be analysed in the recruited subjects. And the the frequency difference will be calculated to explore if any SNP is related to ischemic stroke.
Time frame: up to 3 years
the NIHSS assessed for functional outcome of stroke
NIHSS wil be used to assess neurological status at baseline or the point of stroke, the point of out-patient, 3 month, 6 month, 1 year, 2 year and the 3 year.
Time frame: up to 3 years
the modified Rankin Scale assessed for functional disability
Th functional disability will be assessed using the modified Rankin Scale at the time of baseline, out-patient, 3rd month, 6th month, 1st year, 2nd year and the 3rd year after enrollment.
Time frame: up to 3 years
the Barthel index assessed for functional independence in activities
The Barthel index at the point of baseline, out-patient, 3rd month, 6th month, 1st year, 2nd year and the 3rd year after enrollment will be assessed for the functional independence in activities.
Time frame: up to 3 years
the number of all cause death
The number of all cause of death will be recorded in both groups.
Time frame: up to 3 years
the number of re-stroke in case group
Recurrent of stroke will be monitored through out in case group.
Time frame: up to 3 years
Plan to share: Yes
No publications or documents are linked to this record.
Started Jan 2017 (actual). Primary completion is estimated for Dec 2025, 107 months after the start.
Of 394 non-industry observational studies under Ischemic Stroke, half reached primary completion within 56 months of starting (the median), counting those still running; a quarter within 25 and three quarters within 140. This study's planned 107 months is above that.
Counting every sponsor, half of 436 studies reached it within 53 months; a quarter within 24 and three quarters within 127.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Xi'an No.3 Hospital